世界新药概览-2014年卷

Executive SummaryCHAPTER1．Alectinib HydrochlorideCHAPTER2．Apatinib MesylateCHAPTER3．ApremilastCHAPTER4.AsunaprevirCHAPTER5．AtalurenCHAPTER6．BelinostatCHAPTER7．CeritinibCHAPTER8．ChidamideCHAPTER9．Daclatasvir DihydrochlorideCHAPTER10．DelamanidCHAPTER11．EliglustatTartrateCHAPTER12．EmpagliflozinCHAPTER13．FinafloxacinCHAPTER14．IdelalisibCHAPTER15．IpragliflozinL．ProlineCHAPTER16．Luseogliflozin HydrateCHAPTER17．Naloxegol OxalateCHAPTER18．Nintedanib EsylateCHAPTER19．OlaparibCHAPTER20．Oritavancin DiphosphateCHAPTER21．PhenothrinCHAPTER22．Ripasudil Hydrochloride HyrdrateCHAPTER23．SuvorexantCHAPTER24．TasimelteonCHAPTER25．TavaboroleCHAPTER26．Tedizolid PhosphateCHAPTER27．Tofogliflozin HydrateCHAPTER28．Umeclidinium BromideCHAPTER29．VaniprevirCHAPTER30．VonoprazanFumarateCHAPTER31．VorapaxarSulfateAppendix.AbbreviationAppendixII.SalesWorldwider2014—2015)AppendixIII.WorldwideApproved NCEs(2001—2015)Append&IV.WorldwideApproved NCEs(SortedbyIndication2001—2015)